Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation

NCT06217796 PHASE4 COMPLETED Results posted

Subjects will receive ½ of the approved dose of MydCombi to determine the dilation curve with the reduced dose.

Details

Lead sponsor	Eyenovia Inc.
Phase	PHASE4
Status	COMPLETED
Enrolment	30
Start date	Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Mydriasis

Interventions

• MydCombi

Countries

United States